Dr. Mark F. Sasse, MD

Dr. Sasse practices at Grandview Medical Center in Birmingham, Alabama, part of Community Health.

Dr. Sasse's NPI, 1427019843, was assigned on March 28, 2006. Dr. Sasse graduated from University of Rochester School of Medicine and Dentistry in 1994. Dr. Sasse holds Alabama license 31616.

Dr. Sasse's primary practice is Grandview Medical Center, at 3690 Grandview Parkway, Birmingham, AL 35243 in Jefferson County. The practice phone is (205) 971-1000.

Dr. Sasse's primary practice is Grandview Medical Center in Birmingham, Alabama, part of Community Health. The medical group on file is UAB Medicine. Dmand AI also links Dr. Sasse to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sasse practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Sasse's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Sasse's licenses on file in 2 states: Alabama and Wisconsin.

CMS data shows 1,428 Medicare services from Dr. Sasse across 22 procedure codes in 2024, for 544 Medicare patients. Medicare paid $119,753 for them.

CMS counts 544 Medicare patients who saw Dr. Sasse in 2024. The largest group is 75 to 84, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sasse's median patient age at 72, with 50% women.

In 2024, Dr. Sasse wrote 5,734 Medicare Part D claims for 721 patients. 84% of them were for generic drugs. CMS names the drug for 5,446 of them, across 51 drugs with 11 or more claims each, at $952,969 in total drug cost. In 2023, CMS named 4,287 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sasse for performance year 2024, reported through an alternative payment model (APM). Dr. Sasse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sasse as offering telehealth. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Sasse, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Sasse, published from 2014 to 2019. The most frequent topics are Percutaneous Coronary Intervention, Aortic Valve Stenosis and Coronary Angiography. Dr. Sasse has published most often in Eur Heart J Cardiovasc Imaging. Dr. Sasse's most frequent co-authors are Massoud A. Leesar, Spencer James Melby, MD and Firas Al Solaiman, MD.

Dmand AI links Dr. Sasse to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ventricular Outflow Obstruction and Aortic Valve Stenosis.

CMS Open Payments shows 78 general payments to Dr. Sasse from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $3,597.

Dr. Sasse graduated from University of Rochester School of Medicine and Dentistry in 1994.